Excellere has partnered with executive Geoff Hall to pursue a buy-and-build strategy in the medical products sector.
Mr. Hall has more than 20 years of experience in the medical products, diagnostics and life sciences sectors. Until November 2020, Mr. Hall was the CEO of California-based Pulse Systems, a provider of medical device prototyping and full-scale production with capabilities in laser cutting, laser welding, CNC machining, sub-assembly, and finished device processing. Pulse Systems was sold by United American Healthcare Corporation to Heraeus Medical Components (HMC) in November 2020. HMC is part of Heraeus Holdings, one of the largest family-owned companies in Germany.
From 2010 to 2014, Mr. Hall was the CEO of Oregon-based Precision Wire Components, a medical technology and manufacturing company specializing in guidewire and minimally invasive component design and production. Precision Wire was sold by The Riverside Company to Creganna-Tactx Medical – part of Tyco Electronics – in December 2014. Earlier in his career, from 2003 to 2010, he was with medical device maker Medtronic.
“I’m excited to be working with the Excellere team – they are a terrific group of individuals who have built a strong reputation for performance in an increasingly competitive landscape,” said Mr. Hall. “I look forward to contributing to the firm’s continued success and creating and optimizing value for future medical technology partners and management teams.”
“Joining forces with Geoff enables Excellere to more effectively and efficiently evaluate opportunities within the medical products sector and provides immediate value to our new partners post-closing,” said Ryan Glaws, a managing partner at Excellere. “Geoff’s leadership and industry experience make him a valuable addition to Excellere’ strategic alliance program and resource to our entrepreneur and management team partners.”
Excellere invests in middle-market companies with revenues ranging from $20 million to $150 million. Sectors of interest include business services, healthcare services and products, and industrial growth. The firm has $1.4 billion of capital under management and is based in Denver.
© 2021 Private Equity Professional | August 20, 2021